…R 57–70) years; 58% male; 50% classical phenotype. All received disease-modifying therapy. Focal 68Ga-DOTATATE uptake was present in all patients with he…
All extracted treatments
Showing 661–720 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
Articles mentioning treatments
7,227 articles · page 306 of 603…iac events. Furthermore, regional functional recovery following revascularisation is shown to be highly dependent on infarct transmurality, and s…
…-up 6.5 years (0.01–29.4) and AMH 2.2 (0.01–17.4); 68% received disease-modifying treatment. AMH levels did not differ between patients and controls and we…
…n Diaphragm dysfunction is associated with failure to wean from mechanical ventilation. Inspiratory muscle training (IMT) may help improve outcomes fo…
…ed relief and do not sufficiently address non-cardiac symptoms. Auricular vagal neuromodulation therapy (AVNT) and slow-paced diaphragmatic breathing (SDB) have each d…
…l dysregulation. These insights have fuelled the development of targeted therapies designed to modulate specific immune pathways, aiming to interr…
…team work together to manage the anxiety she experiences during electroconvulsive therapy…
… first-line treatments, and 33/163 patients (20%) also received second-line treatments. Early neurological recovery was observed in 82/164 patients (5…
…ual cohorts: one receiving a DAI cohort and the other receiving treatment-as-usual (TAU cohort). We contrasted incidence rates for ten alcohol-rel…
…or relapse, hospitalisation and damage accumulation risk during maintenance therapy in anti-neutrophil cytoplasmic antibody (ANCA)-associated vascu…
Patient experiences of idiopathic pulmonary fibrosis (IPF) in China: a multicentre qualitative study
…ng disease that profoundly impacts patients’ daily lives. While pharmacological therapies continue to advance, less is known about how patients experienc…
…n particular, gaps were noted in access to respiratory support, physiotherapy and nutritional management. These findings suggest that the app…